Alessandra Cavané

HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.

C. Tripodo, N. Zaffaroni, M. Di Nicola, 2015, Blood.

HSPH1 Inhibition Down-regulates Bcl-6 and c-Myc and Hampers the Growth of Human Aggressive B-cell Non-Hodgkin Lymphoma

C. Tripodo, F. Braud, R. Zappasodi, 2015 .

HSPH 1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma

C. Tripodo, N. Zaffaroni, F. Braud, 2015 .

Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.

M. Dugo, P. Corradini, C. Carniti, 2016, Experimental hematology.

Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma

M. Dugo, P. Corradini, S. Rizzitano, 2019, British Journal of Cancer.

Pleiotropic antitumor effects of the pan‐HDAC inhibitor ITF2357 against c‐Myc‐overexpressing human B‐cell non‐Hodgkin lymphomas

C. Croce, M. Iorio, N. Zaffaroni, 2014, International journal of cancer.

Pleiotropic antitumor effects of the pan‐HDAC inhibitor ITF2357 against c‐Myc‐overexpressing human B‐cell non‐Hodgkin lymphomas

C. Croce, M. Iorio, N. Zaffaroni, 2014, International journal of cancer.